Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies
A new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—the current standard treatment for Helicobacter pylori infection—is declining. Increasing antibiotic resistance of H. pylori is the most significant factor contributing to eradication failure. Thus, selec...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2016/9086581 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567524805312512 |
|---|---|
| author | Ju Yup Lee Kyung Sik Park |
| author_facet | Ju Yup Lee Kyung Sik Park |
| author_sort | Ju Yup Lee |
| collection | DOAJ |
| description | A new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—the current standard treatment for Helicobacter pylori infection—is declining. Increasing antibiotic resistance of H. pylori is the most significant factor contributing to eradication failure. Thus, selecting the most appropriate regimen depending on resistance is optimal, but identifying resistance to specific antibiotics is clinically challenging. In a region suspected to have high clarithromycin resistance, bismuth quadruple therapy and so-called nonbismuth quadruple therapies (sequential, concomitant, and sequential-concomitant hybrid) are some first-line regimen options. However, more research is needed regarding appropriate second-line treatments after first-line treatment failure. Tailored therapy, which is based on antibiotic sensitivity testing, would be optimal but has several limitations for clinical use, and an alternative technique is required. A novel potassium-competitive acid blocker-based eradication regimen could be a valuable eradication option in the near future. |
| format | Article |
| id | doaj-art-7e784ee8e1db480099715ee26353b8c5 |
| institution | Kabale University |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-7e784ee8e1db480099715ee26353b8c52025-02-03T01:01:18ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/90865819086581Optimal First-Line Treatment for Helicobacter pylori Infection: Recent StrategiesJu Yup Lee0Kyung Sik Park1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of KoreaDepartment of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of KoreaA new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—the current standard treatment for Helicobacter pylori infection—is declining. Increasing antibiotic resistance of H. pylori is the most significant factor contributing to eradication failure. Thus, selecting the most appropriate regimen depending on resistance is optimal, but identifying resistance to specific antibiotics is clinically challenging. In a region suspected to have high clarithromycin resistance, bismuth quadruple therapy and so-called nonbismuth quadruple therapies (sequential, concomitant, and sequential-concomitant hybrid) are some first-line regimen options. However, more research is needed regarding appropriate second-line treatments after first-line treatment failure. Tailored therapy, which is based on antibiotic sensitivity testing, would be optimal but has several limitations for clinical use, and an alternative technique is required. A novel potassium-competitive acid blocker-based eradication regimen could be a valuable eradication option in the near future.http://dx.doi.org/10.1155/2016/9086581 |
| spellingShingle | Ju Yup Lee Kyung Sik Park Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies Gastroenterology Research and Practice |
| title | Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies |
| title_full | Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies |
| title_fullStr | Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies |
| title_full_unstemmed | Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies |
| title_short | Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies |
| title_sort | optimal first line treatment for helicobacter pylori infection recent strategies |
| url | http://dx.doi.org/10.1155/2016/9086581 |
| work_keys_str_mv | AT juyuplee optimalfirstlinetreatmentforhelicobacterpyloriinfectionrecentstrategies AT kyungsikpark optimalfirstlinetreatmentforhelicobacterpyloriinfectionrecentstrategies |